Skip to main content

Metluma

MAR: Your Questions on GLP‑1s, Weight and Energy, Answered

MAR: Your Questions on GLP‑1s, Weight and Energy, Answered

March 2026

Metabolic Health & Peri-/Menopause: Your Questions on GLP‑1s, Weight and Energy, Answered 
A live, no‑hype AMA on what really happens to your metabolism in peri‑/menopause, and where GLP‑1 medications do (and don’t) fit in. 
As oestrogen fluctuates and declines in peri‑/menopause, many women notice new belly fat, stubborn weight, and rising blood sugars and cholesterol.  
This AMA will unpack what’s actually happening to your metabolism, how GLP‑1 medications work, and how to protect long‑term health beyond quick fixes. 

What you’ll learn:

  • What is metabolic health and how do we assess it. 
  • Where do GLP‑1’s fit and what are basics: how they work, realistic benefits, and key risks and side‑effects in midlife women. 
  • How GLP‑1s, hormone therapy, and lifestyle (nutrition, movement, sleep) can work together to improve metabolic and cardiovascular health.  
  • What to focus on if you choose not to use – or eventually stop – GLP‑1s, so you can maintain weight and metabolic gains.  
 

We’ll be joined by:

  • Dr Nic Avard, Co-Founder & Chief Medical Officer of Metluma 
  • Jarrah Eddy, Nutritionist and Metluma Co-founder/Head of Education 
  • Dr Jo Sharp, specialised women’s health GP 
Expect to cut through the noise on GLP‑1s, hormone therapy, and lifestyle so you can make informed, personalised decisions with your healthcare team.